Xavier Pujol, Ph.D.
Chief Scientific Officer & CDMO Business Development North America, Farmhispania Group
Professional Overview
Xavier Pujol is an accomplished scientific leader with extensive expertise in the pharmaceutical and biotechnology industries. As the Chief Scientific Officer and CDMO Business Development North America at Farmhispania Group, he is responsible for driving scientific innovation, overseeing research and development, and spearheading the company's expansion in the North American market.
Experience Summary
Current Role
In his current role as the Chief Scientific Officer and CDMO Business Development North America at Farmhispania Group, Dr. Pujol is responsible for leading the company's scientific strategy and driving the development of cutting-edge pharmaceutical and biotechnology solutions. He oversees a team of scientists and researchers, ensuring the seamless integration of scientific capabilities across the organization. Additionally, he is at the forefront of Farmhispania Group's North American market expansion, leveraging his extensive industry knowledge and networking skills to secure new business partnerships and drive growth.
Career Progression
Prior to his current role, Dr. Pujol served as the R&D Director at Farmhispania Group for over a decade, where he spearheaded the development of innovative pharmaceutical products and processes. He has also held various technical and managerial positions at Grupo Uriach, including Process Development Manager, Pilot Plant Manager, and Senior Development Chemist. Earlier in his career, he gained valuable experience as a Lab Technician at Boerhinger Mannheim.
Academic Background
Dr. Pujol holds a Ph.D. in Chemistry from a prestigious university, with a specialization in pharmaceutical process development and optimization. His academic achievements include several peer-reviewed publications and participation in industry conferences, further solidifying his standing as a respected scientific authority in the field.
Areas of Expertise
- Pharmaceutical process development and optimization
- CDMO strategy and operations
- Scientific leadership and team management
- Regulatory compliance and quality assurance
- Business development and strategic partnerships
Professional Impact
Throughout his career, Dr. Pujol has made significant contributions to the pharmaceutical and biotechnology industries. He has led the successful development and commercialization of several innovative drug products, resulting in improved patient outcomes and enhanced company profitability. Additionally, his leadership in the CDMO space has enabled Farmhispania Group to expand its reach and provide high-quality contract manufacturing services to clients across North America.
Conclusion
With his extensive scientific expertise, proven track record of success, and strategic vision, Dr. Xavier Pujol is poised to drive continued growth and innovation at Farmhispania Group. As the Chief Scientific Officer and CDMO Business Development North America, he is well-equipped to guide the company's scientific advancements and solidify its position as a leading player in the global pharmaceutical and biotechnology landscape.
